epirubicin has been researched along with Di Guglielmo Disease in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ju, RJ; Li, N; Li, RJ; Lu, WL; Men, Y; Tian, W; Wang, XX; Yao, HJ; Ying, X; Yu, Y; Zhang, L; Zhang, Y; Zhou, J | 1 |
Cao, YH; Chang, HY; Huang, Y; Jiao, XY; Liu, JH; Ma, FC; Pan, KL; Zhu, HF | 1 |
Hu, X; Pan, Q; Zheng, S | 1 |
Chen, WY; Hu, X | 2 |
Borrel, MN; Fiallo, M; Garnier-Suillerot, A; Priebe, W | 1 |
6 other study(ies) available for epirubicin and Di Guglielmo Disease
Article | Year |
---|---|
The efficacy of mitochondrial targeting antiresistant epirubicin liposomes in treating resistant leukemia in animals.
Topics: Amlodipine; Analysis of Variance; Animals; Antibiotics, Antineoplastic; Caspase 3; Caspase 9; Cell Survival; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; K562 Cells; Leukemia, Erythroblastic, Acute; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Xenograft Model Antitumor Assays | 2011 |
[The study on reversing mechanism of multidrug resistance of K562/A02 cell line by curcumin and erythromycin].
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Proliferation; Cell Survival; Curcumin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Epirubicin; Erythromycin; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; K562 Cells; Leukemia, Erythroblastic, Acute; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2006 |
[Reduced intracellular drug accumulation related to overexpression of P-glycoprotein cannot explain the complete drug resistance in MDR cell variant K562/Dox].
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Epirubicin; Humans; Leukemia, Erythroblastic, Acute; Tumor Cells, Cultured | 1995 |
Restoration of intracellular drug accumulation in MDR cell line K562r does not mean reversal of its drug resistance.
Topics: Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Epirubicin; Humans; Leukemia, Erythroblastic, Acute; Tumor Cells, Cultured | 1994 |
P-glycoprotein-mediated efflux of hydroxyrubicin, a neutral anthracycline derivative, in resistant K562 cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Clone Cells; Doxorubicin; Drug Resistance; Epirubicin; Glucose; Humans; Kinetics; Leukemia, Erythroblastic, Acute; Molecular Structure; Tumor Cells, Cultured | 1994 |
[Intracellular accumulation, retention, and distribution of anthracyclines in a multidrug-resistant variant K562r].
Topics: Antibiotics, Antineoplastic; Cell Nucleus; Chromatography, High Pressure Liquid; Cytoplasm; Daunorubicin; Doxorubicin; Drug Resistance; Epirubicin; Humans; Leukemia, Erythroblastic, Acute; Tumor Cells, Cultured; Verapamil | 1994 |